Dr. Melvin Dana Bullock, MD

Dr. Bullock practices at Gastroenterology Consultants in Roswell, Georgia.

Dr. Bullock's NPI, 1093869786, was assigned on January 22, 2007. Dr. Bullock graduated from Medical College of Georgia in 2006. Dr. Bullock's Georgia license number on file is 63638.

Dr. Bullock's primary practice is Gastroenterology Consultants, at 11685 Alpharetta Hwy, Roswell, GA 30076 in Fulton County. The practice phone is (770) 442-5882.

Dr. Bullock's primary practice is Gastroenterology Consultants in Roswell, Georgia. Dr. Bullock is also affiliated with Wellstar North Fulton Medical Center. The medical group on file is Gastroenterology Consultants. Dmand AI also links Dr. Bullock to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bullock practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bullock's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bullock is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bullock's licenses on file in 2 states: Georgia and Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Bullock treats.

CMS data shows 274 Medicare services from Dr. Bullock across 8 procedure codes in 2024, for 153 Medicare patients. Medicare paid $22,083 for them.

CMS counts 153 Medicare patients who saw Dr. Bullock in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bullock's median patient age at 58, with 48% women.

In 2024, Dr. Bullock wrote 956 Medicare Part D claims for 254 patients. 77% of them were for generic drugs. CMS names the drug for 765 of them, across 21 drugs with 11 or more claims each, at $489,211 in total drug cost. In 2023, CMS named 727 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bullock for performance year 2024, reported through an alternative payment model (APM). CMS lists Dr. Bullock as offering telehealth. CMS counts 117 procedures of colonoscopy by Dr. Bullock, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Bullock, published from 2010 to 2013. Dr. Bullock's most frequent co-authors are Lisa A. Boardman, MD, Bijo K. John, MD and Douglas L. Riegert-Johnson, MD.

Dmand AI links Dr. Bullock to 2 clinical trials, 2 of them phase 4 studies. 2 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Crohn Disease and Colitis. Takeda sponsors the most, 2. Open Payments lists research payments to Dr. Bullock that name 1 trial.

CMS Open Payments shows 486 general payments to Dr. Bullock from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Pfizer Inc. paid the most, $2,565. It also lists 8 research payments totaling $1,301 in 2024, naming 1 clinical trial.

Dmand AI lists 7 awards for Dr. Bullock, most recently ACG/AstraZeneca Clinical Vignette Award in 2012.

Dr. Bullock graduated from Medical College of Georgia in 2006. Dr. Bullock is a member of ACG, AGA, ASGE and CCFA.

Dr. Bullock is in network with 17 carriers, including Aetna, Cigna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.